In Person

Let’s Talk Compliance Series Patients, Payers & Prosecutors: Understanding the Compliance Parameters of Patient Assistance Programs

October 3, 2018
Event details
October 3, 2018
5:30 pm
San Francisco, CA

Event summary

Cooley’s Let’s Talk Compliance Series is a private, invitation only series that allows life sciences companies with newly launched compliance functions to discuss strategies and better practices for ensuring its success. This multi-part series will cover trending compliance topics in a conversational and relaxed atmosphere.

This session will focus on patient assistance programs and will include a discussion of the legal parameters, recent enforcement activity and compliance tips for ensuring that your compliance is ready for success.

Future Let's Talk Compliance Series topics will include:
  • Patient advocacy interactions
  • Federal and state "sunshine" laws
  • Drug pricing and pricing transparency

For more information, please email Amanda Richardson or call +1 617 937 2460.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.